Evidence map›Paper›PMID 31527283›Full record

Trial reportNeurology2019

Risky behaviors and Parkinson disease: A mendelian randomization study.

Sandeep Grover, Christina M Lill, Meike Kasten, Christine Klein, Fabiola Del Greco M, Inke R König

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Neurology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Protective Effects of Genetic Proxies of Cognitive Reserve in Parkinson's Disease: A Longitudinal Multi-Cohort Study.Movement disorders : official journal of the Movement Disorder Society · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Update: Protective and risk factors for Parkinson disease.Parkinsonism & related disorders · 2024
    Review
  9. Article
  10. Article
  11. Clearing the Smoke: What Protects Smokers from Parkinson's Disease?Movement disorders : official journal of the Movement Disorder Society · 2024
    Review
  12. Review
  13. The Interaction between HLA-DRB1 and Smoking in Parkinson's Disease Revisited.Movement disorders : official journal of the Movement Disorder Society · 2022
    Article
  14. Review
  15. Molecular mechanisms defining penetrance ofMedizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.V · 2022
    Article
  16. Systematic review of Mendelian randomization studies on Parkinson's disease.Medizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.V · 2022
    Article
  17. Socioeconomic status, individual behaviors and risk for mental disorders: A Mendelian randomization study.European psychiatry : the journal of the Association of European Psychiatrists · 2022
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Sandeep GroverFrom the Institut für Medizinische Biometrie und Statistik (S.G., I.R.K.), Universität zu Lübeck, Universitätsklinikum Schleswig-Holstein, Campus Lübeck; Genetic and Molecular Epidemiology Group (C.M.L.), Lübeck Interdisciplinary Platform for Genome Analytics, Institutes of Neurogenetics & Cardiogenetics, Institute of Neurogenetics (M.K.), Department of Psychiatry and Psychotherapy, and Institute of Neurogenetics (C.K.), Universität zu Lübeck, Germany; and Institute for Biomedicine (F.D.G.M.), Eurac Research, Bolzano, Italy.ORCID 0000-0003-2615-4916
Christina M LillFrom the Institut für Medizinische Biometrie und Statistik (S.G., I.R.K.), Universität zu Lübeck, Universitätsklinikum Schleswig-Holstein, Campus Lübeck; Genetic and Molecular Epidemiology Group (C.M.L.), Lübeck Interdisciplinary Platform for Genome Analytics, Institutes of Neurogenetics & Cardiogenetics, Institute of Neurogenetics (M.K.), Department of Psychiatry and Psychotherapy, and Institute of Neurogenetics (C.K.), Universität zu Lübeck, Germany; and Institute for Biomedicine (F.D.G.M.), Eurac Research, Bolzano, Italy.
Meike KastenFrom the Institut für Medizinische Biometrie und Statistik (S.G., I.R.K.), Universität zu Lübeck, Universitätsklinikum Schleswig-Holstein, Campus Lübeck; Genetic and Molecular Epidemiology Group (C.M.L.), Lübeck Interdisciplinary Platform for Genome Analytics, Institutes of Neurogenetics & Cardiogenetics, Institute of Neurogenetics (M.K.), Department of Psychiatry and Psychotherapy, and Institute of Neurogenetics (C.K.), Universität zu Lübeck, Germany; and Institute for Biomedicine (F.D.G.M.), Eurac Research, Bolzano, Italy.
Christine KleinFrom the Institut für Medizinische Biometrie und Statistik (S.G., I.R.K.), Universität zu Lübeck, Universitätsklinikum Schleswig-Holstein, Campus Lübeck; Genetic and Molecular Epidemiology Group (C.M.L.), Lübeck Interdisciplinary Platform for Genome Analytics, Institutes of Neurogenetics & Cardiogenetics, Institute of Neurogenetics (M.K.), Department of Psychiatry and Psychotherapy, and Institute of Neurogenetics (C.K.), Universität zu Lübeck, Germany; and Institute for Biomedicine (F.D.G.M.), Eurac Research, Bolzano, Italy.
Fabiola Del Greco MFrom the Institut für Medizinische Biometrie und Statistik (S.G., I.R.K.), Universität zu Lübeck, Universitätsklinikum Schleswig-Holstein, Campus Lübeck; Genetic and Molecular Epidemiology Group (C.M.L.), Lübeck Interdisciplinary Platform for Genome Analytics, Institutes of Neurogenetics & Cardiogenetics, Institute of Neurogenetics (M.K.), Department of Psychiatry and Psychotherapy, and Institute of Neurogenetics (C.K.), Universität zu Lübeck, Germany; and Institute for Biomedicine (F.D.G.M.), Eurac Research, Bolzano, Italy. inke.koenig@imbs.uni-luebeck.de fabiola.delgreco@eurac.edu.ORCID 0000-0002-2805-1307
Inke R KönigFrom the Institut für Medizinische Biometrie und Statistik (S.G., I.R.K.), Universität zu Lübeck, Universitätsklinikum Schleswig-Holstein, Campus Lübeck; Genetic and Molecular Epidemiology Group (C.M.L.), Lübeck Interdisciplinary Platform for Genome Analytics, Institutes of Neurogenetics & Cardiogenetics, Institute of Neurogenetics (M.K.), Department of Psychiatry and Psychotherapy, and Institute of Neurogenetics (C.K.), Universität zu Lübeck, Germany; and Institute for Biomedicine (F.D.G.M.), Eurac Research, Bolzano, Italy. inke.koenig@imbs.uni-luebeck.de fabiola.delgreco@eurac.edu.ORCID 0000-0003-0504-6465

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo examine causal associations between risky behavior phenotypes and Parkinson disease using a mendelian randomization approach.

methodsWe used 2-sample mendelian randomization to generate unconfounded estimates using summary statistics from 2 independent, large meta-analyses of genome-wide association studies on risk-taking behaviors (n = 370,771-939,908) and Parkinson disease (cases n = 9,581, controls n = 33,245). We used the inverse variance weighted method as the main method for judging causality.

resultsOur results support a strong protective association between the tendency to smoke and Parkinson disease (odds ratio [OR] 0.714 per log odds of ever smoking, 95% confidence interval [CI] 0.568-0.897,

conclusionThese findings provide support for a causal relationship between general risk tolerance and Parkinson disease and may provide new insights into the pathogenic mechanisms leading to the development of Parkinson disease.

Indexed as

Genetic Predisposition to DiseaseMendelian Randomization AnalysisFemaleGenome-Wide Association StudyHumansMaleParkinson DiseasePhenotypePolymorphism, Single NucleotideRisk Factors

Identifiers

PMID31527283
PMCPMC7010323

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.